title: [Pyruvate kinase, 2,3 bisphosphoglycerate and fibrin-fibrinogen degradation products in patients with polycythemia, before and after erythrapheresis therapy].
authors.forename: L
authors.initials: L
authors.lastname: Buchtová
authors.forename: J
authors.initials: J
authors.lastname: Hrubesová
authors.forename: C
authors.initials: C
authors.lastname: Krácmar
mesh_terms: D019794:2,3-Diphosphoglycerate; D001781:Blood Component Removal; D004163:Diphosphoglyceric Acids / Q000097:blood*; D017707:Erythrocyte Transfusion; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011086:Polycythemia / Q000097:blood* / Q000628:therapy; D011770:Pyruvate Kinase / Q000097:blood*
chemical_list: D004163:Diphosphoglyceric Acids; D005338:Fibrin Fibrinogen Degradation Products; D019794:2,3-Diphosphoglycerate; D011770:Pyruvate Kinase
vernacular_title: Pyruvátkináza, 2,3 bifosfoglycerát a fibrin-fibrinogen degradacní produkty u nemocných s polycytémií, pred a po lécebné erytraferéze.